Oncology & Cancer

Liquid biopsy results differed substantially between two providers

Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

Oncology & Cancer

Less frequent biopsy may be option in prostate cancer care

(HealthDay)—Biennial biopsies are an acceptable alternative to annual biopsies for men managing low-risk prostate cancer through active surveillance (AS), according to a research published online Nov. 27 in the Annals of ...

Oncology & Cancer

Use of Prostate Health Index test reduces unnecessary biopsies

The Prostate Health Index (phi) is a cost-effective tool used by urologists to detect prostate cancer. It reduces the risk of over diagnosis, and cuts down on the need to send men for unnecessary and often uncomfortable biopsies. ...

Oncology & Cancer

New techniques give blood biopsies greater promise

Researchers at the Broad Institute of MIT and Harvard, Koch Institute at MIT, Dana-Farber Cancer Institute, and Massachusetts General Hospital have developed an accurate, scalable approach for monitoring cancer DNA from blood ...

Oncology & Cancer

Infection is most common complication of prostate biopsy

(HealthDay)—The most common complication of prostate biopsy is infection, with mild bleeding also reported, according to an update of the American Urological Association White Paper published in the August issue of The ...

Oncology & Cancer

Vascular targeted photodynamic tx aids low-risk prostate cancer

(HealthDay)—For men with low-risk prostate cancer, vascular targeted photodynamic therapy achieves an 82 percent rate of absent clinically significant cancer in treated lobes, according to a study published in the August ...

page 6 from 21